LDL

Europe PMC · fetched just now · sorted by publication date

1. 1
   Advances and perspectives in genetically encoded biosensors for biomarker detection and theranostic circuits.

   Xu J, Qi Q, Wang Q. · 2026-09-23

   open access unreviewed
2. 2
   Immuno-resolving nitric oxide-generating stents for coordinated vascular healing.

   Du Z, Yang M, Huang Y, Ma Q, Mou X, Zhang W, Wang Y, Zhu J, Yang Z. · 2026-09-15

   open access unreviewed
3. 3
   A programmable spatiotemporal bioelectrical conduit promotes peripheral nerve regeneration by suppressing ferroptosis through modulation of ER-mitochondria coupling in Schwann cells.

   Wang Z, Jiang A, Wang F, Yang Z, Zhong Y, Yang Y, Tan J, Han W, Li X, He X, Zhang X, Wang J, Han X, Bai D. · 2026-09-16

   open access unreviewed
4. 4
   Transient culture of adult human hepatocytes as organoids improves engineered liver engraftment.

   Saxton SH, Kang I, Mitchell S, Lotto J, Upadhyay A, Zou C, Quirk C, McCray TN, Prado O, Johansson F, Fortin C… · 2026-07-23

   open access unreviewed
5. 5
   The perspective of artificial intelligence for NMR.

   Lin Y, Zheng X, Jiang B, Chen Z, Liu M. · 2026-05-28

   open access unreviewed
6. 6
   Association Between Serum Amylin, Irisin, and Sirtuin 1 in Male Patients with Type 2 Diabetes and Diabetic Nephropathy.

   Sabih Wajdi S, Mohyadini M, Abdlwhab HM, E Jassim W, Bathaie SZ. · 2026-09-20

   open access unreviewed
7. 7
   Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.

   Wang Y, Cao Z, Lan H, Li B, Wang G, Chen Q. · 2026-03-27

   open access unreviewed
8. 8
   Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

   Conti DGA, Tosetti LS, Jablonka F, Hix S, Wolska A, Amar M, Remaley AT, Fonseca FLA. · 2026-07-04

   unreviewed
9. 9
   Implementation of an EHR-supported multidisciplinary lipid management program for suspected familial hypercholesterolemia: Early clinical and implementation outcomes.

   Fishberg RD, Feldman JN, Dubose D, Cooper L, Rutledge J. · 2026-07-11

   open access unreviewed
10. 10
    Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines.

    Spitz JA, Metlock FE, Nriagu B, Ade C, Scheuermann B, Dastmalchi L, Sharma G, Kim S. · 2026-06-26

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.